Statera Biopharma, Inc. (STAB)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Apr 29, 2026, 9:30 AM EST
Statera Biopharma Market Cap
Statera Biopharma has a market cap or net worth of $7.26 thousand as of April 29, 2026.
Market Cap
7.26K
Enterprise Value
n/a
Revenue
3.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since July 28, 2021, Statera Biopharma's market cap has decreased from 170.15M to 7.26K, a decrease of -100.00%. That is a compound annual growth rate of -87.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 7.26K | -66.67% |
| Dec 31, 2025 | 21.78K | 200.01% |
| Dec 31, 2024 | 7.26K | -83.33% |
| Dec 29, 2023 | 43.55K | -99.02% |
| Dec 30, 2022 | 4.44M | -93.99% |
| Dec 31, 2021 | 73.82M | -56.61% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avenue Therapeutics | 1.84M |
| Agentix | 1.76M |
| Protagenic Therapeutics | 1.76M |
| ZyVersa Therapeutics | 1.70M |
| ProtoKinetix | 2.21M |
| AXIM Biotechnologies | 2.22M |
| Clearside Biomedical | 1.62M |
| VitaSpring Biomedical | 2.30M |